![FDA and FTC collaborate on CBD warning letters](https://wallerlawblog.com/wp-content/uploads/2023/12/FDAs-position-on-cannabidiol-CBD.jpg)
Earlier this month, outgoing Food and Drug Administration (FDA) commissioner Scott Gottlieb made a number of statements relating to the FDA’s position on cannabidiol (CBD) used in consumer products, including the announcement of a working group and public hearing on the topic to be held on May 31. Specifically, Commissioner Gottlieb’s statements referenced three warning…